Historical record - last NADAC effective date: 6/19/2024
Product Information
BAXDELA 450 MG TABLET is a brand product labeled by Melinta Therapeutics, LLC, priced at $72.3117 per EA under NDC 70842010102. Its NADAC has been published 61 times since Apr 17, 2024.
FDA first approved this application on Jun 19, 2017.
Strength
450 mg/1
Manufacturer
Melinta Therapeutics, LLCNDC
70842010102
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
DELAFLOXACIN MEGLUMINEApproval Type
New Drug (NDA)
FDA Application
NDA208610FDA Approved
6/19/2017
On Market Since
6/19/2017
Pharmacological Classes
Price Statistics
The NADAC for BAXDELA 450 MG TABLET has been published 61 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $72.3117 per EA |
|---|---|
| All-time high | $72.3117 (Jun 11, 2025) |
| All-time low | $72.3117 (Apr 17, 2024) |
| Median price | $72.3117 |
| Average price | $72.3117 |
| Largest weekly change | 0.0% (Apr 24, 2024) |
| Weeks tracked | 61 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Jun 11, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BAXDELA 450 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BAXDELA 450 MG TABLET, manufactured by Melinta Therapeutics, LLC, is $72.3117 per EA (NDC 70842010102), effective Jun 11, 2025.
How has the price of BAXDELA 450 MG TABLET changed over time?
Over the history we have for it, the NADAC for BAXDELA 450 MG TABLET has held within roughly two percent of its current level. It has been tracked across 61 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BAXDELA 450 MG TABLET?
Since Apr 17, 2024, the NADAC for BAXDELA 450 MG TABLET has ranged from a low of $72.3117 (Apr 17, 2024) to a high of $72.3117 (Jun 11, 2025), with a median of $72.3117 per EA.
Are there cheaper alternatives to BAXDELA 450 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BAXDELA 450 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BAXDELA 450 MG TABLET?
BAXDELA 450 MG TABLET (NDC 70842010102) is labeled by Melinta Therapeutics, LLC, and CMS classifies it as a brand product.